We use cookies to make sure our website better meets your expectations.
You can adjust your web browser's settings to stop accepting cookies. For further information, read our cookie policy.
SEARCH
IN Warsaw
Exchange Rates
Warsaw Stock Exchange - Indices
The Warsaw Voice » Business » December 21, 2011
Business & Economy
You have to be logged in to use the ReadSpeaker utility and listen to a text. It's free-of-charge. Just log in to the site or register if you are not registered user yet.
Advancing Cancer Research
December 21, 2011   
Article's tools:
Print

Belgian company Ion Beam Applications (IBA) will supply new research equipment to the Polish Academy of Sciences’ Henryk Niewodniczański Institute of Nuclear Physics (IFJ) in Cracow under a deal announced in early November. Under the deal, IBA will supply the extension of the IFJ Proton Therapy Center, the partners said.

Previously, in 2010, IBA was selected to handle the first phase of this project, which included the supply of a cyclotron and associated equipment.

The agreement for the second phase of development of the PT center amounts to between 15 and 20 million euros, executives said. It includes a gantry treatment room and associated building. The building work will be subcontracted by IBA to a major European building contractor.The gantry treatment room will allow the IFJ to treat patients using a state-of-the-art radiation delivery technique called Pencil Beam Scanning. This advanced treatment method allows physicians to precisely “paint the targeted cells” in 3D, with the treatment beam, thus further optimizing the targeting of the tumor while sparing the surrounding healthy tissue. The aim is limit the short-term side effects of the treatment and preserve the quality of life of patients over the long term.Prof. Marek Jeżabek, director general of the IFJ, said that, thanks to the deal with IBA, “the first proton therapy center equipped with a modern Gantry Treatment Room and a scanning beam will be built in Poland, marking a breakthrough in cancer treatment.”

Pierre Mottet, chief executive officer of IBA, said the deal “confirms IBA’s position as a leading expert and a trusted partner for the development and delivery of Proton Therapy treatment facilities around the world. We are honored to partner again with the prestigious Polish Academy of Sciences and help them advance cancer treatment in Poland.”The IFJ Proton Therapy Center will be IBA’s fifth clinical proton therapy center in Europe. Worldwide, IBA has supplied treatment equipment to 21 proton therapy centers, over half the total number of facilities of this kind.
© The Warsaw Voice 2010-2018
E-mail Marketing Powered by SARE